Pharmala Biotech Quote - MDMA | ADVFN

S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
Canada
CSE
Pharmala Biotech Holdings Inc (MDMA) Share Price

Pharmala Biotech Holdings Inc (MDMA)

0.235

-0.005

(-2.08%)

Closed December 20 3:00PM

Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Current Price

0.235

Bid

0.225

Ask

0.25

Volume

135,315

0.225 Day's Range 0.265

0.065 52 Week Range 0.35

Previous Close

0.24

Open

0.245

Last Trade

Last Trade Time

Average Volume (3m)

476,466

Financial Volume

-

VWAP

-

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.005	2.17391304348	0.23	0.265	0.195	596156	0.24340168	CS
4	-0.035	-12.962962963	0.27	0.33	0.195	413820	0.28101599	CS
12	0.15	176.470588235	0.085	0.34	0.075	476466	0.23356799	CS
26	0.11	88	0.125	0.34	0.065	319380	0.1912906	CS
52	0.095	67.8571428571	0.14	0.35	0.065	414059	0.19844596	CS
156	-0.205	-46.5909090909	0.44	0.54	0.02	572855	0.19070284	CS
260	-0.205	-46.5909090909	0.44	0.54	0.02	572855	0.19070284	CS

MDMA - Frequently Asked Questions (FAQ)

What is the current Pharmala Biotech share price?

The current share price of Pharmala Biotech is $ 0.235

What is the 1 year trading range for Pharmala Biotech share price?

Pharmala Biotech has traded in the range of $ 0.065 to $ 0.35 during the past year

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
XBLK.XeXeBlock Technology Corporation	$ 0.05 (150.00%)	312.24k
CCRGreen River Gold Corp	$ 0.01 (100.00%)	2.1k
KVMKingsview Minerals Ltd	$ 0.01 (100.00%)	1,000
MYTCMyndTec Inc	$ 0.20 (100.00%)	1,000
AJNAJN Resources Inc	$ 0.10 (81.82%)	12k
XCXAMP Alternative Medical Products Inc	$ 0.01 (-89.47%)	2k
MJRXGlobal Health Clinics Ltd	$ 0.01 (-75.00%)	7.5k
NIRVNirvana Life Sciences Inc	$ 0.025 (-66.67%)	3k
CLSHCLS Holdings USA Inc	$ 0.02 (-60.00%)	60.26k
PMAXPowermax Minerals Inc	$ 0.70 (-51.72%)	5.5k
TRIPRed Light Holland Corp	$ 0.04 (0.00%)	3.53M
QIMCQuebec Innovative Materials Corp	$ 0.09 (5.88%)	2.17M
SOLSOL Global Investments Corp	$ 0.36 (0.00%)	2.05M
HODLSol Strategies Inc	$ 2.64 (23.36%)	1.73M
AFXArctic Fox Lithium Corp	$ 0.005 (-50.00%)	1.45M

lolroflmao

lolroflmao 1 month ago

PharmAla Reaches Agreement In Principle to Supply MDMA to Clinical Trial in Exchange for Full Data License

https://pharmala.ca/media/2024/11/pharmala-reaches-agreement-in-principle-to-supply-mdma-to-clinical-trial-in-exchange-for-full-data-license

lolroflmao

lolroflmao 1 month ago

News: PharmAla to supply LaNeo MDMA for Clinical Trial at Yale

https://pharmala.ca/media/2024/11/pharmala-to-supply-laneo-mdma-for-clinical-trial-at-yale

lolroflmao

lolroflmao 2 months ago

PharmAla to supply Mt. Sinai Hospital with LaNeo MDMA Press Release | 10/21/2024

https://www.otcmarkets.com/stock/MDXXF/news/PharmAla-to-supply-Mt-Sinai-Hospital-with-LaNeo-MDMA?id=456329

lolroflmao

lolroflmao 2 months ago

PharmAla to supply the University of Texas, San Antonio, with novel dosage form of LaNeo™ MDMA Press Release | 10/08/2024

https://www.otcmarkets.com/stock/MDXXF/news/PharmAla-to-supply-the-University-of-Texas-San-Antonio-with-novel-dosage-form-of-LaNeo-MDMA?id=455196

lolroflmao

lolroflmao 2 months ago

PharmAla to supply Harvard Medical School’s Maclean Hospital with LaNeo MDMAPress Release | 10/02/2024
https://www.otcmarkets.com/stock/MDXXF/news/PharmAla-to-supply-Harvard-Medical-Schools-Maclean-Hospital-with-LaNeo-MDMA?id=454666

lolroflmao

lolroflmao 2 months ago

PharmAla to supply Johns Hopkins Medicine for Clinical TrialPress Release | 09/11/2024

https://www.otcmarkets.com/stock/MDXXF/news/PharmAla-to-supply-Johns-Hopkins-Medicine-for-Clinical-Trial?id=452770

Dewayne18

Dewayne18 2 years ago

$MDMA New Short Call: Shorts in at 30 cents today. Stay tuned tomorrow for details of its pending doom. Last call 34% in less than 2 days.

Dewayne18

Dewayne18 2 years ago

$MDMA SHORT ALERT!!!

Company up on lousy $50,000 deal.... Shorts in at 38 cents CDN.

Quick 30%

Act Now!!!

Dewayne18

Dewayne18 2 years ago

$MDMA is looking like the perfect short. The SP is racing up and the company only has 700K left with shares doubling up in the past 12 months. Over the past 12 months cash went down by 1.2 million.

Forcealpine

Forcealpine 3 years ago

It looks like this IPO has gone similarly to all psych companies have. The industry needs a massive correction, but that cannot happen until government stop obsessing over vaccines and start promoting alternative solutions to the gigantic mental health crisis ongoing and perpetuating daily while being ignored. MDMA looks promising and I'll be keeping a very close eye on its news and resulting share price.

Pharmala Biotech

Pasquarelli Auto

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions